Inhibition of Lipopolysaccharide-Induced Interleukin 8 in Human Adenocarcinoma Cell Line HT-29 by Spore Probiotics: B. coagulans and B. subtilis (natto)

Probiotics and Antimicrobial Proteins

Volumn 9, Issue 1, 2017, Pages 56-63

  Azimirad, Masoumeh ^a,b   Alebouyeh, Masoud ^a   Naji, Tahereh ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Bacillus coagulans; Bacillus subtilis (natto); Immunomodulatory effect; Lipopolysaccharide

Indexed keywords

INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROBIOTIC AGENT; ANTIINFLAMMATORY AGENT;

ADENOCARCINOMA CELL LINE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACILLUS COAGULANS; BACILLUS SUBTILIS; BACTERIAL COLONIZATION; BACTERIAL SPORE; CELL ADHESION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; INTESTINE EPITHELIUM CELL; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BACILLUS; DRUG EFFECT; GENETICS; HT-29 CELL LINE; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS; BACILLUS; BACILLUS SUBTILIS; CELL LINE, TUMOR; HT29 CELLS; HUMANS; INTERLEUKIN-8; INTESTINES; LIPOPOLYSACCHARIDES; PROBIOTICS; SPORES, BACTERIAL;

EID: 84992379409     PISSN: 18671306     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12602-016-9234-x     Document Type: Article

References (42)

1. Alebouyeh M, Behzadian-Nejad Q, Soleimani M, Hassan ZM, Salmanian AH, Zali MR (2009) Characterization of the interaction of undomesticated Bacillus subtilis spores with Caco-2 cell line. Ann Microbiol 59:273–277
2. Benson KF, Redman KA, Carter SG, Keller D, Farmer S, Endres JR, Jensen GS (2012) Probiotic metabolites from Bacillus coagulans GanedenBC30TM support maturation of antigen-presenting cells in vitro. WJG 18:1875
3. Blaut M, Clavel T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137:751S–755S
4. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker H-C, Podolsky DK (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. J Immunol 164:966–972
5. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689–10692
6. Ciprandi G, Vizzaccaro A, Cirillo I, Tosca MA (2005) Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study. Eur Ann Allergy Clin Immunol 37:129–134
7. de Souza RD, Batista MT, Luiz WB, Cavalcante RCM, Amorim JH, Bizerra RSP, Martins EG, de Souza Ferreira LC (2014) Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. PLoS ONE 9:e87454
8. Duc LH, Hong HA, Fairweather N, Ricca E, Cutting SM (2003) Bacterial spores as vaccine vehicles. Infect Immun 71:2810–2818
9. Endres J, Clewell A, Jade K, Farber T, Hauswirth J, Schauss A (2009) Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 47:1231–1238
10. Faille C, Jullien C, Fontaine F, Bellon-Fontaine M-N, Slomianny C, Benezech T (2002) Adhesion of Bacillus spores and Escherichia coli cells to inert surfaces: role of surface hydrophobicity. Can J Microbiol 48:728–738
11. Fedorak RN, Madsen KL (2004) Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 10:286–299
12. Finamore A, Roselli M, Imbinto A, Seeboth J, Oswald IP, Mengheri E (2014) Lactobacillus amylovorus inhibits the TLR4 inflammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal Caco-2 cells and pig explants. PLoS ONE 9:e94891
13. Foligné B, Peys E, Vandenkerckhove J, Dewulf J, Breton J, Pot B (2012) Spores from two distinct colony types of the strain Bacillus subtilis PB6 substantiate anti-inflammatory probiotic effects in mice. Clin Nutr 31:987–994
14. Food and Agriculture Organisation, and World Health Organization (2006) Probiotics in food: health and nutritional properties and guidelines for evaluation. FAO, Rome
15. Haddad JJ, Abdel-Karim NE (2011) NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation? Cell Immunol 271:5–14
16. Hardy H, Harris J, Lyon E, Beal J, Foey AD (2013) Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5:1869–1912
17. Hong HA, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813–835
18. Hong HA, Duc LH, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813–835
19. Hosoi T, Hirose R, Saegusa S, Ametani A, Kiuchi K, Kaminogawa S (2003) Cytokine responses of human intestinal epithelial-like Caco-2 cells to the nonpathogenic bacterium Bacillus subtilis (natto). Int J Food Microbiol 82:255–264
20. Isolauri E, Kirjavainen P, Salminen S (2002) Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 50:iii54–iii59
21. Joshi LT, Phillips DS, Williams CF, Alyousef A, Baillie L (2012) Contribution of spores to the ability of Clostridium difficile to adhere to surfaces. Appl Environ Microbiol 78:7671–7679
22. Kirjavainen P, Mattila-Sandholm T, Saarela M (2003) Probiotics and the management of food allergy. In: Functional dairy products. Woodhead Publishing Limited, pp 108–131
23. Kozuka S, Tochikubo K (1985) Properties and origin of filamentous appendages on spores of Bacillus cereus. Microbiol Immunol 29:21–37
24. La Ragione RM, Woodward MJ (2003) Competitive exclusion by Bacillus subtilis spores of salmonella enterica serotype enteritidis and clostridium perfringens in young chickens. Vet Microbiol 94:245–256
25. La Ragione RM, Casula G, Cutting SM, Woodward MJ (2001) Bacillus subtilis spores competitively exclude Escherichia coli O78: K80 in poultry. Vet Microbiol 79:133–142
26. Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, Rayes N, Sherman PM, Timmerman HM, Vaneechoutte M, Van Loo J (2007) Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev 65:469–489
27. Long KZ, Rosado JL, Santos JI, Haas M, Al Mamun A, DuPont HL, Nanthakumar NN, Estrada-Garcia T (2010) Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections. Infect Immun 78:1221–1228
28. Martínez-Maqueda D, Miralles B, Recio I (2015) HT29 cell line. In: The impact of food bioactives on health. Springer, Berlin, pp 113–124
29. Medvedev A, Kopydlowski K, Vogel S (2000) Expression chemokine, and toll-like receptor 2 and 4 gene macrophages: deregulation of cytokine, transduction in endotoxin-tolerated mouse inhibition of lipopolysaccharide-induced signal. J Immunol 164:5564–5574
30. Moré MI, Swidsinski A (2015) Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis: a review. Clin Exp Gastroenterol 11:237
31. Moue M, Tohno M, Shimazu T, Kido T, Aso H, Saito T, Kitazawa H (2008) Toll-like receptor 4 and cytokine expression involved in functional immune response in an originally established porcine intestinal epitheliocyte cell line. BBA 1780:134–144
32. O’Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol 7:353–364
33. O’Sullivan G, Kelly P, O’Halloran S, Collins C, Collins J, Dunne C, Shanahan F (2005) Probiotics: an emerging therapy. Curr Pharmaceut Des 11:3–10
34. Pesce G, Rusciano G, Sasso A, Isticato R, Sirec T, Ricca E (2014) Surface charge and hydrodynamic coefficient measurements of Bacillus subtilis spore by optical tweezers. Biointerfaces 116:568–575
35. Sabet M, Cottam HB, Guiney DG (2006) Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages. FEMS Immunol Med Microbiol 47:369–379
36. Sánchez B, Arias S, Chaignepain S, Denayrolles M, Schmitter J, Bressollier P, Urdaci M (2009) Identification of surface proteins involved in the adhesion of a probiotic Bacillus cereus strain to mucin and fibronectin. Microbiology 155:1708–1716
37. Sudha RM, Sunita M, Sekhar BM (2011) Safety studies of Bacillus coagulans unique IS-2 in rats: morphological, biochemical and clinical evaluations. Int J Probiotics Prebiotics 6:43–48
38. Taverniti V, Guglielmetti S (2011) The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr 6:261–274
39. Tekin IO, Oral HB, Shiri-Sverdlov R (2015) Mediators of gut mucosal immunity and inflammation. Mediat Inflamm 2015:765303
40. Wheeler DS, Chase MA, Senft AP, Poynter SE, Wong HR, Page K (2009) Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via toll-like receptor (TLR)-4. Resp Res 10:1
41. Zeytun A, Chaudhary A, Pardington P, Cary RB, Gupta G (2010) Induction of cytokines and chemokines by toll-like receptor signaling: strategies for control of infammation. Crit Rev Immunol 30(1):53–67
42. Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS (2005) Differential induction of the toll-like receptor 4-MyD88-dependent and-independent signaling pathways by endotoxins. Infect Immun 73:2940–2950